Superworth

PROCEPT BioRobotics price to book ratio PRCT

Market value divided by the book value of the company's net assets, since 2021.

Today, Nov 2, 2026
3.3×
5-year median
7.5×
Against its 5-year history
5th
percentile: 0 is its lowest day, 100 its highest
5-year range
2.7× to 21.4×
Peer median
3.7×

PROCEPT BioRobotics' price to book ratio is 3.3× as of Nov 2, 2026.

That is below its 5-year median of 7.5×, lower than on 95% of days in the last 5 years.

Over that time it ranged from 2.7× in Jan 2022 to 21.4× in Nov 2024.

The median for 10 medical instruments and supplies stocks of a similar size is 3.7×.

Price to book ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far3.3×2.7×4.8×
20254.8×4.4×18.8×
202417.7×6.9×21.4×
20237.1×5.2×10.1×
20228.4×2.7×9.5×
20213.8×3.8×6.3×

Against its peers

Companies in Medical - Instruments & Supplies nearest PROCEPT BioRobotics' size, closest first, today.

CompanyPrice to book ratio
PRCTPROCEPT BioRobotics3.3×
BVSBioventus4.8×
IARTIntegra Lifesciences1.0×
IRMDIradimed9.5×
STAAStaar Surgical3.4×
CDRECadre3.9×
EYENational Vision1.5×
MOVMovado1.4×
LMATLemaitre Vascular4.4×
INSPInspire Medical Systems2.4×
UFPTUFP Technologies4.8×
Peer median3.7×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on PROCEPT BioRobotics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.